Elevance Health, Inc. (NYSE: ELV) is considered one of the best magic formula stocks to invest in. Wells Fargo maintained an Overweight rating on ELV but reduced its price target from $478 to $400 on July 15. The firm cited margin uncertainty in the Medicaid, Medicare Advantage, and Health Insurance Exchange segments for 2025 as the reason for the price target cut. Wells Fargo applied a lower multiple of 10.5x to its 2026 earnings per share projection of $38.05. Elevance Health, Inc. offers a variety of health insurance products under brands like Anthem Blue Cross and Blue Shield.

Wells Fargo highlighted concerns about margin visibility in the Medicaid and Health Insurance Exchange segments for 2026. The firm stated that Elevance’s valuation remains compelling once estimates settle. Elevance Health, Inc., formerly known as Anthem, Inc., is a leading health-benefits provider in the U.S. offering medical, pharmaceutical, dental, and more.

While Elevance Health, Inc. (NYSE: ELV) presents potential as an investment, other AI stocks may offer greater upside with less downside risk. A free report on the best short-term AI stock is available for those interested. For more investment options, check out the 10 Best Magic Formula Stocks for 2025 and 10 Best Retirement Stocks to Buy According to Hedge Funds.

Read more at Yahoo Finance: Wells Fargo Cuts Elevance (ELV) Price Target on Margin Uncertainty